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Abbreviations: 
5-OP-RU 5-(2-oxopropylideneamino)-6-d-ribityllumazine 
CD  Cluster of differentiation 
CIA  Collagen induced arthritis 
COPD  Chronic obstructive pulmonary disease 
EAE  Experimental autoimmune encephalomyelitis 
ER  Endoplasmic reticulum 
GI  Gastrointestinal 
HLA  human leukocyte antigen 
IBD  Inflammatory bowel disease 
ICS  Inhaled corticosteroids 
IFN  Interferon 
IL  Interleukin 
iNKT  Invariant natural killer T  
MAIT  Mucosal associated invariant T 
MHC  Major histocompatibility complex 
MS  Multiple sclerosis 
MR1  Major histocompatibility complex-related protein 1 
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PD1  Programmed cell death protein 1  
PCR  Polymerase chain reaction 
PLZF  Promyelocytic leukemia zinc finger protein 
RhA  Rheumatoid arthritis 
RORt Retinoic acid receptor-related orphan receptor  t 
SLE  Systemic lupus erythematosus  
TCR  T cell receptor 
TG  Transgenic 
Th  T helper 
TNBS  2,4,6-Trinitrobenzenesulfonic acid 
TNF  Tissue necrosis factor 
TRAV  T cell receptor  chain variable region 
TRVB  T cell receptor  chain variable region 
XIAP  X-linked inhibitor of apoptosis 
XLP  X-linked lymphoproliferative syndrome 
Summary  
Mucosal associated invariant T (MAIT) cells are a novel class of innate-like T cells, 
expressing a semi-invariant T cell receptor and able to recognize small molecules 
presented on the non-polymorphic MHC-related protein 1. Their intrinsic effector-
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relative abundance in humans implies a significant potential to contribute to 
autoimmune processes. However, as MAIT cells were unknown until recently and 
specific immunological tools were unavailable, to date little is known of their roles in 
disease. Here I review observations from clinical studies and animal models of 
autoimmune and immune mediated diseases including the roles of MAIT cells in 
systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, inflammatory 
bowel disease and airways diseases. MAIT cell deficiencies are frequently observed 
in peripheral blood, and at sites of disease such as the airways in asthma. However 
MAIT cells have a specific sensitivity to suppression by therapeutic corticosteroids 
that may confound many of these observations, as may the tendency of the surface 
marker CD161 to activation-induced down-regulation. Nonetheless the dependence 
on bacteria for the development of MAIT cells suggests a potentially important 
protective role linking the influences of early life microbial exposures and subsequent 
development of autoimmunity. Conversely MAIT cells could contribute to chronic 
inflammation either through TCR-independent activation, or potentially by TCR 
recognition of as-yet undiscovered ligands. Future research will be greatly facilitated 
by the immunological tools now available, including murine genetic models and 
human and murine specific tetramers.   
 
Text 
Mucosal associated invariant T (MAIT) cells are a subset of innate-like T 
lymphocytes first described in 19991, which are abundant in humans and can rapidly 
express a range of pro-inflammatory cytokines. Whilst MAIT cells express an  T 
cell receptor (TCR) they differ from conventional T cells in that this receptor has a 
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with a limited repertoire of TCR- chains[BOX 1]. Furthermore MAIT cells are 
restricted not by major histocompatibility complex (MHC), but by the non-
polymorphic class 1b antigen presenting molecule MHC-related protein 1 (MR1)2,3. 
Ligands for MAIT cells remained elusive until the recent demonstration by Kjer-
Nielsen et al that MR1 presented non-protein antigens which include precursors and 
derivatives from highly conserved biosynthetic pathways of riboflavin and folic acid 
metabolism in bacteria, mycobacteria and yeast4-6. To date only these limited 
classes of ligands – most importantly the naturally occurring activating ligand 5-(2-
oxopropylideneamino)-6-d-ribityllumazine (5-OP-RU)7 -– have been identified for 
MR1 and it remains to be seen whether other classes of ligand exist.    
 
TEXT BOX 1 MAIT cell TCR- MR1 recognition 
As with other innate-like lymphocytes, MAIT cells express a semi-invariant 
TCR.  Most MAIT cell TCRs comprise a semi-invariant TCR- chain – usually 
TRAV1-2-TRAJ33 (V7.2-J33 in humans, V19-J33 in mice)8, although in 
humans some MAIT cells also use TRAV1-2-TRAJ12 or TRAV1-2-TRAJ209) – 
predominantly associated with the -chains TRBV20 (V2) or TRBV6 (V13) 
in humans1 and TRBV19 (V6) or TRBV13 (V8) in mice1,9,10. These 
preferential TCR rearrangements arise partly through a process of 
‘convergent recombination’11 whereby much of the antigen specificity of MAIT 
cells is essentially germline-encoded. This feature, alongside the striking 
evolutionary conservation of MR1 across over 150 million years of 
mammalian evolution3,12-15, implies a strong evolutionary pressure maintaining 
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This limited diversity of MAIT-TCR, and the abundance of MAIT cells in 
humans means that, early in an immune response MAIT cells may markedly 
outnumber responses from conventional peptide-specific  T cells16. 
Currently, whilst there is a growing understanding of the role of MAIT cells in host 
protection from intracellular pathogens17-22 (Figure 1), very little is known concerning 
the roles these cells play in disease. Several features suggest potential relevance to 
immune mediated pathology. MAIT cells display an intrinsic effector-memory 
phenotype – i.e. without the need for prior clonal expansion16 –  typically CD45RA-
CD45RO+CD95HiCD62LLoCD44Hi2,23-25 and can rapidly secrete a range of pro-
inflammatory cytokines including tissue necrosis factor (TNF)-, interleukin (IL)-17, 
and IFN-, and also the type 2 cytokine IL-4 on TCR ligation23,25. MAIT cells share 
some similarities with invariant natural killer T (iNKT) cells, which are implicated in 
many autoimmune conditions26,27, including expression of a semi-invariant TCR, 
restriction by non-classical MHC molecules, and expression of the transcription 
factor PLZF28 although many differences exist, notably the nature of the ligands and 
the restriction molecule. Other significant features are the remarkable abundance of 
MAIT cells, which comprise approximately 5% of T cells in peripheral blood20,25 and 
20-40% of liver T cells in humans23,29, and their wide tissue distribution  in blood, 
mucosal tissues, liver and joints9,10,23,27,30,31.  A peculiarity of MAIT cell biology is that 
although MR1 expression is ubiquitous3,32, it is normally found only at very low levels 
on the cell surface32-34. This has led to speculation that if other classes of MAIT cell 
ligand exist, they might include autologous molecules whose presentation at the cell 
surface occurs only when MR1 surface expression is upregulated as a signal of cell 
stress2,33,35, as occurs with other class 1b molecules16,36. Inappropriate triggering of 
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Nonetheless, to date, data regarding MAIT cells in immune mediated disease are 
scant, at least partly because MAIT cells were unknown until recently and specific 
immunological tools, such as relevant antibodies, transgenic models24,30,37 and 
specific tetramers for humans7,9 and mice25, were unavailable. Furthermore, due to 
the limited diversity of the MAIT TCR and the non-polymorphic, non-human 
leukocyte antigen (HLA) encoded nature of MR1, it is unlikely there will be 
pathological auto-reactive MAIT cells leading directly to HLA-associated diseases 
meeting the stringent definition of a classic autoimmune disease38. Instead, in this 
paper I will review observational data of MAIT frequency and function in human 
immune mediated diseases, alongside mechanistic data from relevant murine 
models. These studies are summarised in Table 1. I will then discuss the relevance 
of corticosteroids and receptor down-regulation to these studies, the potential of 
MAIT cells to act as non-specific effectors of inflammation, and speculate on their 
relevance in early life origins of immune disease and some potential therapeutic 
implications. 
It is important to compare and contrast the biology of MAIT cells in humans and in 
mice, as differences may explain some discrepancies between human disease and 
animal models. In both species MAIT cells express orthologous TCR- chains, are 
MR1-restricted and recognise the same antigen. In both species MAIT cells express 
the master transcription factor PLZF and signature surface markers including CD127 
(IL7R), CD218 (IL18R), CCR9 and CCR625. However, by contrast MAIT cells are 
at least 10-fold less abundant in mice than in humans25,33. Whilst some other 
previously reported species differences may have been artefacts of a specific 
transgenic murine model25, other differences include a more limited expression of 
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IL-17 is abundantly produced by both mouse and human MAIT cells in response to 
mitogen, but in humans IL-17 is not produced in response to TCR triggering25,31,39. In 
general each section of this review discusses human data from clinical studies first, 
before addressing murine data where relevant.  
 
Observations from specific diseases 
Systemic lupus erythematosus and rheumatoid arthritis 
Systemic lupus erythematosus (SLE), an archetypal multi-system autoimmune 
disease, is considered a multifactorial disorder with evidence of genetic 
susceptibility, environmental triggers including infections, and dysregulation of innate 
and adaptive immunity40,41. The pro-inflammatory cytokine IL-17 is associated with 
SLE and correlated with disease activity42,43, whilst IL-17-producing T-helper (Th) 17 
cells are involved in driving local inflammation at sites of disease44,45. MAIT cells are 
potent producers of IL-17 and due to their similar cytometric profile may in fact have 
constituted many of the ‘Th17’ populations measured in these studies46. Local 
cytokine production by MAIT cells within tissues could contribute to lowering 
quantitative threshold of immune signalling, a process believed to interact with 
genetic predispositions to contribute to the initial pathogenic processes in SLE41. 
Furthermore, several non-MHC loci contribute to genetic predisposition to SLE41, so 
potentially polymorphisms in MR1 or other MAIT-cell related genes could contribute 
to such predispositions, although to date these have not been described. 
An important feature of MAIT cells is that they can be stimulated by cytokines without 
the need for specific TCR stimulation. Thus human and murine MAIT cells can 
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Given their abundance this may constitute the most important effect of MAIT cells in 
autoimmunity as they non-specifically amplify pro-inflammatory signals within the 
cytokine milieu, enhancing inflammation in both rheumatological conditions like SLE 
and other diseases.  
Cho et al report a reduced frequency of human MAIT cells in peripheral blood in 
patients with both SLE and rheumatoid arthritis (RhA), particularly in the CD8+ and 
double negative subsets, which correlated with disease activity scores in both 
conditions27. Furthermore frequencies of MAIT cells secreting IFN- (though not IL-
17 or IL-4) were reduced in peripheral blood in SLE, with a similar trend in RhA, 
attributable to a defect in Ca2+/calcineurin/NFAT1 signalling. This study reported 
increased expression of the coinhibitory molecule programmed cell death protein 1 
(PD1), perhaps a consequence of chronic MAIT-cell activation leading to T cell 
exhaustion. At the site of disease MAIT cells were increased in synovial tissue in 
human RhA27, and thus might contribute to maturation and cross-differentiation of T 
cells within the tissue microenvironment41. These findings suggest possible 
recruitment of MAIT cells to sites of disease. 
 
It should be noted that in this study, as with all the human clinical studies described 
in this review, MAIT cells were defined by surface phenotype (TCR V7.2+CD161Hi) 
but not using MAIT cell-specific tetramers, and are therefore susceptible to 
confounding by CD161 down-regulation, as occurs with MAIT cell stimulation9,48,49, 
which may lead to a failure to detect MAIT cells48 which are truly present in the 
clinical samples. Of greater significance here is potential confounding by 
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sensitive to therapeutic corticosteroids which cause a rapid decrease in MAIT cell 
frequencies50,51. Indeed Cho et al observed decreased MAIT cell frequencies only in 
SLE and RhA patients, of which 90% were receiving corticosteroids, but no 
deficiency in two other autoimmune diseases also studied – ankylosing spondylitis 
and Behçet’s – in which no patients were receiving steroids27. Although their 
regression analysis did not detect steroid use as a significant coefficient, this may 
have been apparent if more non-steroid treated patients were available for analysis 
or steroid dose had been analysed as a continuous variable. Irrespective of the 
effects of therapy, in such observational studies it is hard to determine causality: 
whether changes in MAIT cell frequency are a primary effect or merely reflect a 
response to cytokines produced by immune dysregulation41. 
By contrast with this observed MAIT cell deficiency, a pathogenic role is implied by 
data from a murine collagen induced arthritis (CIA) model. Chiba et al found MR1-/- 
mice, which lack MAIT cells, had reduced severity of CIA and of collagen antibody-
induced arthritis, whilst CIA was recapitulated by reconstitution with adoptively 
transferred MAIT cells46. As antigen-specific responses of other T and B cells were 
unaffected by the presence of MR1, MAIT cells seem to be acting as effectors rather 
than initiators of inflammation in this model. 
Multiple sclerosis  
Autoimmune T cell responses by Th1 and Th17 cells against components of myelin 
play an important pathogenic role in multiple sclerosis (MS) and other demyelinating 
conditions52. In humans MAIT cells were first reported in inflammatory lesions in MS, 
chronic inflammatory demyelinating polyneuropathy53 and neurological tumours54 
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important to verify the specificity of these cells as non-MAIT cells can express V7.2. 
More recently, using cytometry, frequencies of V7.2+CD161+ MAIT cells have been 
shown to be decreased in peripheral blood in MS patients, particularly during 
disease relapse, compared with remission55, and MAIT cell frequencies increased in 
paired samples 2-3 months after cessation of corticosteroid therapy. MAIT cells 
expressed CCR5 and CCR6 necessary for CNS invasion, suggesting they might 
preferentially migrate to CNS lesions, and peripheral MAIT frequencies correlated 
positively with frequencies of iNKT and natural killer (NK) cells. This study sampled 
peripheral blood only and again these findings, particularly the paired analysis of 
relapse and post-relapse remission, will be confounded by the use of corticosteroids, 
which are central to the management of MS relapse, and which may have long-
lasting suppressive effects on MAIT cell frequencies.  
 
Nonetheless elegant murine data from experimental autoimmune encephalomyelitis 
(EAE), a murine model of MS, supports a potentially protective role of MAIT cells in 
neuro-inflammation.  As there is no specific antibody for the canonical V19i TCR 
chain in mice, and wild type mice have very few MR1-restricted T cells, Croxford et 
al used transgenic (TG) mice overexpressing V19i TCR, in which T cells which 
express the NK marker NK1.1+ are enriched for MAIT cells expressing V19-J33 
TCR with V6 or V8 TCR chains56. EAE incidence and severity were decreased in 
V19i TG mice by clinical and histological scores, and spinal cord lesions had less 
infiltration by monocytes and CD4+ T cells, with less demyelination. Similarly EAE 
was ameliorated in wild type mice by adoptive transfer of V19i T cells. Lymph node 
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Conversely MR1-/- mice, which lack MAIT cells, showed more severe EAE, with 
earlier onset, and more T cell proliferation and pro-inflammatory cytokine production, 
with less IL-10 production. In co-culture studies V19i T cells induced IL-10 from 
iNKT cells and conventional T cells, but most potently from CD19+ B cells, and this 
was, at least partly, by an MR1 independent mechanism via ICOS-B7RP-1 
interactions. One important limitation of the methodology used in this and other24,30,37 
studies is that the V19i population includes many MHC-restricted ‘MAIT-like’ cells 
which do not stain with the specific MR1 tetramer or express signature innate cell 
transcription factors like promyelocytic leukemia zinc finger protein (PLZF)9,25. 
Together these findings suggest that MAIT cells are protective against autoimmune 
demyelinating inflammation by a suppressive effect on other B and T cells, 
particularly by enhancing IL-10 secretion and inhibiting Th1 cytokines. 
Inflammatory bowel disease and enteropathies 
MAIT cells were shown early on to be present in the human gut lamina propria1,2, to 
express the guy homing α4β7integrin, and have been considered to be preferentially 
located in mucosal tissue33. Moreover an important role in gastrointestinal (GI) 
mucosal immunity is suggested by the dependence on commensal gut flora for their 
development in mice2,24. It is therefore likely that MAIT cells play a role in disorders 
of GI mucosal immunity. 
Chronic haemorrhagic colitis is a common feature of X-linked lymphoproliferative 
syndrome (XLP) type 228,57. XLP-2 is a rare human genetic immunodeficiency due to 
mutations in the X-linked inhibitor of apoptosis (XIAP) gene, leading to effects 
including increased apoptosis of iNKT and MAIT cells28,57. XLP was therefore the 
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with a 10-fold decrease in peripheral blood MAIT cell frequencies28. Colitis occurs in 
17% of patients with XLP-2 and resembles a severe form of inflammatory bowel 
disease, with accumulations of activated T cells and a mortality of 60% 57. Whilst 
XIAP deficiency may have pleiotropic effects on the immune system, including 
hypogammaglobulinaemia, it seems likely that the colitis is a direct consequence of 
the MAIT cell deficiency. 
Crohn’s disease is believed to be initiated and driven by CD4+ T cells targeting the 
commensal gut microbiota, and secreting IL-12, -17, TNF and IFN 35. Ulcerative 
colitis is likely to involve similar mechanisms, but also Th2 cells secreting IL-5 and -
13 and CD1d-restricted type II NKT cells58,59. As with SLE, RhA and MS, in cross-
sectional observational studies there is a deficiency of human MAIT cells in 
peripheral blood in both Crohn’s disease and ulcerative colitis35,60, although at least 
some of this effect is likely to be attributable to current or recent use of therapeutic 
corticosteroids, whether topical or systemic61. Other possible factors include 
selective apoptosis of MAIT cells due to chronic activation-induced cell death or 
recruitment to sites of disease. Indeed, consistent with the former possibility, Serriari 
et al observed increased expression of the activation markers Ki67, NKG2D and 
BTLA receptor in human blood MAIT cells, which also had enhanced IL-17 
production35. Consistent with the latter suggestion these authors also observed >4 
fold accumulation of CD3+IL18R+V7.2+ MAIT cells in inflamed biopsies from 
Crohn’s disease ileum compared with biopsies from healthy sections35.  
It is not clear whether MAIT cells actively contribute to this inflammation. One report 
suggests that adoptive MAIT transfer is protective in a murine TNBS colitis model, 
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confounded by a non-MAIT conventional T cells62. It seems more likely from their 
known cytokine secretion profile that they would contribute to inflammation at sites of 
disease. Given the known role of MAIT cells in responding to riboflavin-synthesising 
microbes it is also possible that MAIT cell recruitment and activation is a 
consequence of the dysbiosis of the GI microbiome which occurs in inflammatory 
bowel disease63,64. By contrast human lamina propria and blood V7.2+CD161+ 
MAIT cells are deficient in untreated coeliac disease65, another important 
autoimmune enteropathy66. Coeliac is driven by exposure to dietary gluten in 
genetically predisposed people, but can be associated with compromised mucosal 
barrier function and bacterial overgrowth and therefore the potential for activation-
induced MAIT cell death65. 
Airways diseases 
The role innate-like lymphocytes play in airways disease has evoked some 
controversy67-69. Whilst iNKT are implicated in murine models of allergic airways 
disease, they are rare in the human airways68, whilst MAIT cells are five to tenfold 
more abundant than in mice33. Asthma is characterised by airways inflammation, 
classically associated with activated allergen-specific Th2 cells70 secreting IL-4,-5 
and -13, which orchestrate the function of eosinophils, mast cells and B cells50,71. 
There is increasing recognition of disease heterogeneity and some genetic72,73 and 
murine74,75 data implicating IL-17 in certain phenotypes of asthma. We conducted a 
large-scale bronchoscopy-based study of 60 patients spanning the spectrum of 
asthma severity and phenotypes and 24 healthy controls analysing multiple T cell 
subsets in the context of deep clinical and immunological phenotyping50. We found 
no evidence of dysregulation of IL-17 secreting CD4+ Th17 cells, but observed a 
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samples50,51(Figure 2). This deficiency correlated with disease severity in both blood 
and sputum and was associated with poor asthma control, poor lung function, longer 
disease duration and dose of inhaled corticosteroids (ICS). We conducted two open-
label clinical trials of inhaled and oral corticosteroids. There was no change in blood 
or sputum MAIT cell frequencies with 7 days moderate dose ICS (twice daily Qvar 
200 g), but there was a significant 23% decrease in peripheral blood MAIT cell 
frequencies (P=0.03) with just 7 days of systemic corticosteroids (once daily 
prednisolone 20mg). This effect was specific to MAIT cells, as it was not observed 
with V7.2 TCR-expressing conventional T cells50,51. 
We have since observed a similar deficiency of blood and bronchial biopsy MAIT 
cells in chronic obstructive pulmonary disease (COPD), apparent only in individuals 
receiving therapeutic ICS (Hinks et al unpublished observations).  Together these 
findings have important implications both for the management of airways diseases 
and for other conditions. It is remarkable that a systemic deficiency in peripheral 
blood MAIT cells can be induced even by the small doses of corticosteroid which are 
absorbed systemically after administration of low dose ICS76, such as the moderate 
asthmatics in our study who received a median 400g beclomethasone dipropionate 
daily equivalent. Therefore it seems likely that much of the observational human data 
from other diseases discussed in this review are attributable, at least in part, to 
current or recent corticosteroid therapy.  
What might be the consequences of these therapy-induced deficiencies? MAIT cells 
are likely to contribute significantly to protection from pulmonary infections. Indeed 
27% of individuals with XLP-2 suffer from recurrent respiratory infections57, although 
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airway MAIT cells might underlie the increased risk of pneumonia and invasive 
pneumococcal disease associated with severe asthma77,78 and increased pneumonia 
risk in subjects with COPD receiving inhaled fluticasone79,80, or contribute to chronic 
airway colonisation with riboflavin-synthesising pathogens, notably Haemophilus 
influenza in asthma and COPD81. 
 
Whilst MAIT cells are likely to protect against chronic bacterial infections of the 
airways, they may also play a role in the pathogenesis of allergic disease. Most 
MAIT cells secrete type-1 cytokines certainly some clones can produce type-2 
cytokines10,25,56. It is possible that in early life during initiating events in the 
development of allergic and autoimmune disease, such conditions are associated 
with a skewing towards a type-2 cytokine secreting profile in MAIT cells, as occurs 
with other T cell subsets50,70, and may occur early in life. Exposure to microbes 
during early childhood is associated with protection from immune-mediated 
diseases82-84. One mechanism may be persistent effects on innate-lymphocyte 
numbers and function, such as the accumulation of iNKT cells which occurs in the 
lamina propria and lungs of germ free mice, resulting in increased morbidity in 
models of IBD and allergic airways inflammation83,85. As commensal flora are 
absolutely required for MAIT cell development, differences in early life exposures 
would be expected also to impose long-lasting effects on MAIT cells, which could 
well play an important role in the tendency towards the initial development of atopy, 
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Obesity and type II diabetes 
There is a growing recognition of important immune components to a wider range of 
diseases than previously considered, and this gives a potentially broader relevance 
of MAIT cells. For example adipose tissue is immunologically active and obesity 
causes a sterile inflammation86 in which iNKT may play an immunoregulatory 
role87,88.  MAIT cells may contribute to this inflammation as in human obesity they 
are enriched in adipose tissue compared with blood, and have a shift towards higher 
IL-17 production and reduced IL-10 secretion88,89. In peripheral blood MAIT cell 
frequencies are reduced in obesity and in type 2 diabetes, even below the limit of 
detection in some severely obese individuals88, and display a more activated 
phenotype, with upregulated CD25 and IL-17 production. Both these studies found 
correlations between MAIT frequencies and insulin resistance, perhaps related to IL-
17 production, and Magalhaes et al observed some normalisation of MAIT cell 
phenotype and number after bariatric surgery. Thus MAIT cells may act as effectors 
contributing to the pathology of obesity associated insulin resistance. Furthermore, 
as with IBD, obesity is associated with dysbiosis90 which may therefore affect 
gastrointestinal MAIT cell functions and contribute to the poorly understood 
mechanistic links between the microbiome and obesity.  
 
Perspective and future directions 
Several common themes emerge from these studies, summarised in Figure 3. 
Although our knowledge of the emerging field of MAIT cell biology is limited, several 
factors implicate these cells in immune mediated diseases, including their pro-
inflammatory profile46, their widespread tissue distribution and effector-memory 
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therapeutic steroids, and others which use a V7.2CD161+ definition of MAIT cells 
may be confounded by the down regulation of CD161 which occurs with chronic 
activation9,91. Moreover most clinical data are only observational, making it hard to 
determine whether aberrations are primary phenomena, or perhaps represent a 
response to the effects of a disordered cytokine milieu41. Indeed given their 
remarkable abundance and the potential for TCR-independent activation of MAIT 
cells by cytokines such as IL-12, -18 and -23 the most important effects of MAIT cells 
in autoimmunity could be non-specific amplification of inflammatory cytokines leading 
to increased IFN-47 and IL-1727,46. Differences between murine models and human 
studies may be due to such confounding factors in human studies as well as 
differences between the species. 
The following questions should constitute priorities for future research. What other 
ligands can MAIT cells recognise? Do MAIT cells display significant reactivity to self-
ligands? How can MAIT cells distinguish between colonisation and infection, leading 
to immune tolerance or inflammation? Can a lack of early life MAIT-cell stimulation 
contribute to the development of autoimmunity41,92 and allergy82, perhaps through a 
skewing towards a type-2 cytokine profile, or a deficiency of MAIT cells? Do MAIT 
cells undergo activation-induced depletion in autoimmune disease?  
The tools necessary to answer these questions now exist, including specific human9 
and murine25 MR-1 tetramers, antibodies against MR193 and the MAIT cell TCR30, 
and transgenic mice overexpressing V19 T cells24,30,37,94. The strong evolutionary 
conservation of MR1 suggests these tools will soon reveal some critical immune 
functions for these enigmatic cells. Furthermore as the MAIT cell ligands are small 
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inhibitory ligands95, making it an exciting time to speculate on the range of clinical 
applications which will surely emerge.  
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Figure legends 
Figure 1. Over view of human MAIT cell biology 
Invasive bacteria capable of synthesising the riboflavin enter epithelial cells. 
Intermediate products of riboflavin synthesis such as 5-OP-RU synthesised in the 
endosome, or potentially delivered by endocytosis, are loaded onto MR1 in the 
endoplasmic reticulum and transported to the cell surface via the Golgi apparatus. At 
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MAIT cell invariant T cell receptor which is predominantly composed of TRAV1-2-
TRAJ33  chains assembled with TRBV20 or TRBV6 chains. Activation leads to 
release of perforin and granzyme B, which may directly lyse infected cells, and 
proinflammatory cytokines including TNF-, IFN-, IL-17 as well as other cytokines 
which may include the type-2 cytokines IL-4, IL-5 or the immunoregulatory cytokine 
IL-10. MAIT cells typically express the innate lymphocyte transcription factors PLZF 
and RORt and the surface molecules CD161, IL-12R, IL18R and IL-23R. 
 
Abbreviations: 5-OP-RU, 5-(2-oxopropylideneamino)-6-d-ribityllumazine; 2M, -2-
microglobulin; CD cluster of differentiation; ER, endoplasmic reticulum; IL, 
interleukin; INF, interferon; MAIT, Mucosal associated invariant T; 
MR1, major histocompatibility complex-related protein 1; PLZF promyelocytic 
leukaemia zinc finger protein; RORt, retinoic acid receptor-related orphan receptor  
t; TCR, T cell receptor; TRAV, T cell receptor  chain variable region; TRVB, T cell 
receptor  chain variable region. 
 
 
Figure 2. MAIT cells are deficient in asthma and this is related to corticosteroids.  
Frequencies of Vα7.2+CD161+ (MAIT)-cells as a proportion of total live CD3+ T cells 
(A) in peripheral blood, sputum, bronchoalveolar-lavage (BAL) and bronchial 
biopsies in health and asthma. Horizontal lines represent medians. P values are for 
unpaired t tests on log-transformed data. Frequencies of MAIT cells in (B) peripheral 
blood and (C) induced sputum correlate inversely with dose of inhaled corticosteroid. 
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days treatment with 20mg oral prednisolone in 12 subjects with moderate asthma 
(23% fall in median frequency, P values are for paired t tests). 
BDP, beclomethasone dipropionate; rs, Spearman’s correlation coefficient.  
Figure adapted from Elsevier Hinks, T.S., Zhou, X., Staples, K.J., Dimitrov, B.D., 
Manta, A., Petrossian, T., Lum, P.Y., Smith, C.G., Ward, J.A., Howarth, P.H., Walls, 
A.F., Gadola, S.D., Djukanovic, R., March 5, 2015. Innate and adaptive T cells in 
asthmatic patients: relationship to severity and disease mechanisms. J. Allergy Clin. 
Immunol. 136 (2) 323-33 http://dx.doi.org/10.1016/j.jaci.2015.01.014 50. 
 
Figure 3. Graphical summary: MAIT cells in immune mediated disease 
A deficiency of MAIT cells in peripheral blood is likely due to several factors: 
suppression of MAIT cell frequencies by corticosteroids, activation-induced cell 
death and down-regulation of the popular marker CD161. The consequences of such 
a deficiency may include increased risk of pneumonia and invasive infections. MAIT 
cells are enriched at sites of disease, probably due to local proliferation and 
recruitment, and up-regulate activation markers including NKG2D, BTLA and Ki67. 
Chronic stimulation may lead to T cell exhaustion with PD-1 up-regulation. Secretion 
of pro-inflammatory cytokines, especially IL-17 will contribute to inflammation in 
inflammatory bowel disease, SLE and obesity. Non-TCR mediated secretion of IL-17 
may be driven by IL-23 and secretion of IFN- can be driven by IL-12 and IL-18, 
allowing MAIT cells to amplify inflammatory signals in a non-specific manner. It is 
possible that in allergic disease MAIT cells have a bias towards secretion of type-2 
cytokines, whilst in early life microbial exposures may drive MAIT cells to produce a 
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cells may be protective in multiple sclerosis by inducing IL-10 from T cells and 
particularly B cells by an MR1 independent mechanism via ICOS-B7RP-1 
interaction. 
Abbreviations: B7RP-1, B7 related protein-1; ICOS, inducible T cell co-stimulator. 
 
 
Table 1 Human and murine studies on MAIT cells in immune mediated disease 







Model MAIT augmentation MAIT depletion
Rheumatological	diseases
ê  correlating with 
disease activity 
Yes MAIT cells are likely effector 
cells
Cho et al  2014
êIFN-γ-secreting 
MAIT 
Chiba et al  2012
éPD1 expression
Rheumatoid arthritis ê correlating with 
disease activity
é in synovium in 
disease
Yes





in MS and CIDP
Yes EAE ê incidence and 
severity in Vα19i TG 
mice
Illes et al  2004
ê by adoptive 
transfer of Vα19i 
cells.
Miyazaki et al 2011, 
Croxford et al 2006
Inflammatory bowel disease
Crohn's ê with MAIT cell 
activation
é in ileal tissue in 
disease
Yes TNBS ê severity after 
adoptive MAIT 
Murine data confounded by non-
MAIT conventional T cells
Ulcerative colitis ê Yes
Coeliac disease ê ê in lamina propria No Dunne et al 2013
Airway diseases
Asthma ê if taking ICS ê in sputum and 
bronchial biopsies if 
taking ICS
Yes Deficency might contribute to 
increased risks of pneumonia. 
Potential protective role of MAIT 
cells in early life.
Hinks et al 2015 J 
Allergy Clin Immunol, 
Hinks et al 2015 
Lancet
COPD ê if taking ICS ê in bronchial 
biopsies if taking ICS
Yes Unpublished 
observations
Obesity ê and normalises 
after bariatic surgery
é in adipose tissue in 
obesity
Associated with insulin 
resistance
Mahalhaes et al 2015, 
Carolan et al 2015






Serriari et al 2014, 
Hiejima et al 2015, 
Hinks 2015 Inflamm 
Bowel Dis
é severity after 
adoptive MAIT 
transfer
ê severity in MR1-/-
é severity in MR1-/-, 
with éinflammatory 
cytokines and êIL-10
Murine data suggest MAIT cells 
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